Max Healthcare Institute Limited has provided an update regarding ongoing legal proceedings before the Hon’ble National Company Law Tribunal, Cuttack Bench, concerning its subsidiary, Kalinga Hospital Ltd. Interlocutory petitions filed by legal representatives of BRS Capital Two Pte. Limited were heard today, October 29, 2026. The hearing was adjourned due to paucity of time and will resume on October 30, 2026. Details are provided as per SEBI regulations.
Disclosure on Legal Proceedings
Max Healthcare Institute Limited has issued a disclosure concerning petitions filed before the Hon’ble National Company Law Tribunal, Cuttack Bench. These petitions involve interlocutory matters related to Kalinga Hospital Ltd. (‘KHL’), a subsidiary of Max Healthcare. The petitions were filed by the legal representatives of BRS Capital Two Pte. Limited, a shareholder from whom Max Healthcare acquired a majority equity stake in KHL.
Hearing Status and Adjournment
The matter was listed for hearing today, October 29, 2026, at 2:30 PM IST. However, the Hon’ble NCLT could not proceed with the hearing due to paucity of time. Consequently, the matter has been adjourned to October 30, 2026, for further hearing. Max Healthcare is committed to providing timely updates on significant developments in this case as required by regulatory bodies.
Regulatory Compliance
This disclosure is made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Further details pertaining to the proceedings are enclosed as an annexure to this communication. The information will also be available on the company’s official website, www.maxhealthcare.in.
Source: BSE
